Smokeless Tobacco Treatment Companies
Smokeless tobacco treatment typically involves products and interventions designed to help individuals quit or reduce their use of smokeless tobacco products, such as chewing tobacco or snuff.
Smokeless tobacco treatment typically involves products and interventions designed to help individuals quit or reduce their use of smokeless tobacco products, such as chewing tobacco or snuff.
Latest Smokeless Tobacco Companies Updates:
Pfizer (US) announced positive results from a Phase 3 clinical trial of its investigational drug Zyban (bupropion) for smokeless tobacco cessation, demonstrating its efficacy in reducing smokeless tobacco use and promoting abstinence.
GlaxoSmithKline (UK) received FDA approval for its nicotine patch, NicoDerm CQ, for smokeless tobacco cessation, expanding treatment options for users seeking to quit.CBT-Solutions (US) launched a new digital therapy program specifically designed for smokeless tobacco cessation, offering online cognitive behavioral therapy modules and support resources.
Quit Genius (UK) partnered with several health organizations to implement its Quit Genius app, a digital smoking and smokeless tobacco cessation program, in community-based settings.
List of Smokeless Tobacco Key companies in the market:
Smokeless Tobacco Treatment Market Highlights:
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)